161 related articles for article (PubMed ID: 29788649)
21. Personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
[TBL] [Abstract][Full Text] [Related]
22. Current Trends in Personalized Medicine and Companion Diagnostics: A Summary From the DIA Meeting on Personalized Medicine and Companion Diagnostics.
Tsourounis M; Stuart J; Pignato W; Toscani M; Barone J
Ther Innov Regul Sci; 2015 Jul; 49(4):530-543. PubMed ID: 30222427
[TBL] [Abstract][Full Text] [Related]
23. Rules for medical markets: the impact of medicare contractors on coverage policies.
Foote SB; Wholey D; Halpern R
Health Serv Res; 2006 Jun; 41(3 Pt 1):721-42. PubMed ID: 16704509
[TBL] [Abstract][Full Text] [Related]
24. Integration of new technology into clinical practice after FDA approval.
Govil A; Hao SC
J Interv Card Electrophysiol; 2016 Oct; 47(1):19-27. PubMed ID: 27565971
[TBL] [Abstract][Full Text] [Related]
25. [Current situation and challenges in companion diagnostics development].
Nishida M
Gan To Kagaku Ryoho; 2014 Dec; 41(13):2529-34. PubMed ID: 25596043
[TBL] [Abstract][Full Text] [Related]
26. Paving the road to personalized medicine: recommendations on regulatory, intellectual property and reimbursement challenges.
Knowles L; Luth W; Bubela T
J Law Biosci; 2017 Dec; 4(3):453-506. PubMed ID: 29868182
[TBL] [Abstract][Full Text] [Related]
27. EU policies in personalized medicine-related technologies.
Gaisser S; Vignola-Gagné E; Hüsing B; Enzing C; van der Valk T
Per Med; 2009 Jan; 6(1):93-102. PubMed ID: 29783384
[TBL] [Abstract][Full Text] [Related]
28. [Companion diagnostics and reimbursement system].
Tazawa Y
Rinsho Byori; 2013 May; 61(5):435-42. PubMed ID: 23947184
[TBL] [Abstract][Full Text] [Related]
29. Proposed Medicare Physician Payment Schedule for 2017: Impact on Interventional Pain Management Practices.
Manchikanti L; Kaye AD; Hirsch JA
Pain Physician; 2016; 19(7):E935-55. PubMed ID: 27676687
[TBL] [Abstract][Full Text] [Related]
30. Improving the power of diagnostics in the era of targeted therapy and personalized healthcare.
Walk EE
Curr Opin Drug Discov Devel; 2010 Mar; 13(2):226-34. PubMed ID: 20205056
[TBL] [Abstract][Full Text] [Related]
31. Transitional care management reimbursement to reduce COPD readmission.
Kangovi S; Grande D
Chest; 2014 Jan; 145(1):149-155. PubMed ID: 24394826
[TBL] [Abstract][Full Text] [Related]
32. The use of the 'linked evidence approach' to guide policy on the reimbursement of personalized medicines.
Merlin T
Per Med; 2014 Jun; 11(4):435-448. PubMed ID: 29783477
[TBL] [Abstract][Full Text] [Related]
33. The new era of personalized medicine: 10 years later.
Jørgensen JT; Winther H
Per Med; 2009 Jul; 6(4):423-428. PubMed ID: 29783540
[TBL] [Abstract][Full Text] [Related]
34. The impact of new trends in POCTs for companion diagnostics, non-invasive testing and molecular diagnostics.
Huckle D
Expert Rev Mol Diagn; 2015 Jun; 15(6):815-27. PubMed ID: 25990929
[TBL] [Abstract][Full Text] [Related]
35. Physician payment outlook for 2012: déjà vu.
Manchikanti L; Singh V; Caraway DL; Benyamin RM; Falco FJ; Hirsch JA
Pain Physician; 2012; 15(1):E27-52. PubMed ID: 22270747
[TBL] [Abstract][Full Text] [Related]
36. Challenges of implementing personalized (precision) medicine: a focus on diabetes.
Fodor A; Karnieli E
Per Med; 2016 Sep; 13(5):485-497. PubMed ID: 29767596
[TBL] [Abstract][Full Text] [Related]
37. Declassifying coverage. New guidance documents issued by the CMS may clarify the great unknown of Medicare coverage determination.
Barr P
Mod Healthc; 2005 Mar; 35(12):6-7, 1. PubMed ID: 15801288
[TBL] [Abstract][Full Text] [Related]
38. Medicare program; revisions to payment policies under the physician fee schedule for calendar year 2005. Final rule with comment period.
Centers for Medicare & Medicaid Services (CMS), HHS
Fed Regist; 2004 Nov; 69(219):66235-915. PubMed ID: 15551493
[TBL] [Abstract][Full Text] [Related]
39. Are Medicare plans complying with CMS regulation?
Cohen J; Young B; Rochon S; Faden L
Expert Rev Pharmacoecon Outcomes Res; 2008 Apr; 8(2):133-9. PubMed ID: 20528402
[TBL] [Abstract][Full Text] [Related]
40. Personalized medicine: elusive dream or imminent reality?
Lesko LJ
Clin Pharmacol Ther; 2007 Jun; 81(6):807-16. PubMed ID: 17505496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
